Sponsors (2)
The resolution raises public and policymaker awareness of diabetes and its burdens (potentially guiding future action), but it provides no funding or binding programs, so tangible benefits depend on subsequent policy steps.
General public: Increased public awareness of diabetes (e.g., American Diabetes Month), which can lead to earlier detection and better self-management.
People with diabetes and other chronic conditions: Findings could prompt greater recognition and targeted prevention or programs that improve care and outcomes if policymakers act on them.
Veterans receiving VA care: The findings call out higher diabetes rates among VA patients and could lead to more focused outreach or resources for veterans if followed by policy changes.
Taxpayers/general public: The resolution contains no direct funding or program mandates, so increased awareness may not translate into concrete services or improved care.
Middle-class families/taxpayers: Emphasizing the high cost burden of diabetes could raise expectations for policy action that this findings-only resolution does not guarantee.
Based on analysis of 2 sections of legislative text.
Recognizes November as American Diabetes Month and records federal findings on diabetes prevalence, costs, risks, prevention, management, and lack of a cure as of Nov 2025.
Recognizes November as American Diabetes Month and records a series of factual findings about diabetes in the United States. The resolution cites prevalence and demographic data, costs to the health system, risks for complications, effective prevention and management approaches, and notes that there is no cure as of November 2025.
Introduced November 20, 2025 by Jeanne Shaheen · Last progress November 20, 2025